Press releases
- Aurora Cannabis Announces Appointment of New Director
- Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market
- Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products
- Aurora Cannabis Commends Germany's Landmark Legalization Achievement
- Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance
- Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
- Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
More ▼
Key statistics
As of last trade Aurora Cannabis Inc (21P:FRA) traded at 6.10, -43.44% below its 52-week high of 10.79, set on Sep 12, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.02 |
---|---|
High | 6.10 |
Low | 5.95 |
Bid | 6.15 |
Offer | 6.22 |
Previous close | 5.98 |
Average volume | 125.33k |
---|---|
Shares outstanding | 54.54m |
Free float | 54.54m |
P/E (TTM) | -- |
Market cap | 483.40m CAD |
EPS (TTM) | -3.39 CAD |
Data delayed at least 15 minutes, as of May 24 2024 16:21 BST.
More ▼